Search

everythinglearnresearchcommunity

for

Search:↓

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Clofazimine may be effective for treating ashy dermatosis.

Clofazimine successfully treated a man's ashy dermatosis, clearing his skin lesions.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Decorin helps keep hair follicle stem cells and may prevent age-related hair loss.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Pilose antler extracts help hair growth by activating hair follicle stem cells.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.